Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas

Overview of attention for article published in Frontiers in immunology, October 2021

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 82 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 34,173 followers.

RT @FrontImmunol: New Research: Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas: The prognosis of malignant gl…

05 Oct 2021

Reply Repost Favourite

New Research: Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas: The prognosis of malignant gliomas remains poor, with median survival fewer than 20 months and a 5-year survival rate merely 5%. Their primary… https://t.co/QWqtu77

05 Oct 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.